HPS Pharmacies wish to give notice that Juniper Biologics is discontinuing Akynzeo® IV vials as follows:
Akynzeo® IV Vials
Fosnetupitant 235 mg + Palonosetron 250 microgram
ARTG 349310
Akynzeo® IV has been discontinued in January 2026. Akynzeo® capsules are not affected by this notice.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Juniper Biologics on 1800 281 493 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates